ADVERTISEMENT
clpp onc201 mechanism of action cancer drug clinical trial
Found: A Cancer Drug’s Mechanism of Action
As ONC201 moves through human clinical trials, scientists finally figure out that the compound and its analogs target a mitochondrial protease.
Found: A Cancer Drug’s Mechanism of Action
Found: A Cancer Drug’s Mechanism of Action

As ONC201 moves through human clinical trials, scientists finally figure out that the compound and its analogs target a mitochondrial protease.

As ONC201 moves through human clinical trials, scientists finally figure out that the compound and its analogs target a mitochondrial protease.

cell & molecular biology, cancer, biochemistry

David Sabatini: Demystifying mTOR
Cristina Luiggi | Mar 1, 2012 | 2 min read
Principal Investigator, Whitehead Institute for Biomedical Research. Associate Professor, Department of Biology, Massachusetts Institute of Technology. Age: 44
Shielding Cancer Cells from Damage
Tia Ghose | Nov 3, 2011 | 2 min read
An alternative form of an enzyme involved in the glucose metabolism pathway protects cancer cells from oxidative stress.
BRCA1 Further Elucidated
Cristina Luiggi | Oct 27, 2011 | 4 min read
Researchers have pinpointed the region of a key cancer gene that’s involved in tumor suppression.
ADVERTISEMENT